This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Should You Buy, Sell or Hold Braze Ahead of Q2 Earnings Report?
by Shuvra Shankar Dey
BRZE's second-quarter fiscal 2025 earnings and revenues are likely to increase year over year.
DocuSign Stock Before Q2 Earnings: To Buy or Not to Buy?
by Shuvra Shankar Dey
DOCU's second-quarter fiscal 2025 earnings and revenues are likely to increase year over year.
Salesforce.com (CRM) Reliance on International Sales: What Investors Need to Know
by Zacks Equity Research
Explore Salesforce.com's (CRM) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.
Is Trending Stock Salesforce Inc. (CRM) a Buy Now?
by Zacks Equity Research
Salesforce.com (CRM) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Time to Buy Salesforce (CRM) Stock After Strong Q2 Results?
by Shaun Pruitt
Salesforce (CRM) continued its transformation efforts to provide stronger financial figures after beating Q2 expectations on Wednesday and raising its profit guidance.
Why Salesforce.com (CRM) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Don't Overlook This Highly Ranked Stock After Earnings
by Shaun Pruitt
Standing out in terms of value now appears to be a good time to buy Victoria's Secret's (VSCO) stock after surpassing Q2 top and bottom line expectations on Wednesday.
Salesforce's Q2 Earnings Beat: Can Upbeat Profit View Lift CRM Stock?
by Zacks Equity Research
CRM's Q2 earnings reflect the benefits of resilient demand for its solution amid macroeconomic uncertainties and cost-restructuring initiatives.
The Zacks Analyst Blog Highlights NVIDIA, Salesforce and CrowdStrike
by Zacks Equity Research
NVIDIA, Salesforce and CrowdStrike are included in this Analyst Blog.
NVIDIA Beats and Raises in Q2; CRM, CRWD Beat on Earnings
by Mark Vickery
The most important stock on the planet, NVIDIA (NVDA), just reported Q2 earnings after the closing bell today.
Compared to Estimates, Salesforce.com (CRM) Q2 Earnings: A Look at Key Metrics
by Zacks Equity Research
Although the revenue and EPS for Salesforce.com (CRM) give a sense of how its business performed in the quarter ended July 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Salesforce.com (CRM) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Salesforce.com (CRM) delivered earnings and revenue surprises of 8.94% and 1.04%, respectively, for the quarter ended July 2024. Do the numbers hold clues to what lies ahead for the stock?
Slowdown in Sales to Hurt Salesforce's (CRM) Q2 Earnings Growth
by Zacks Equity Research
Salesforce's (CRM) Q2 earnings growth might have been negatively impacted by sluggish sales growth due to the soft IT spending environment.
Durable Goods Orders Increase Highest Since May 2020
by Zacks Equity Research
Durable Goods Orders Increase Highest Since May 2020.
Pre-Markets Mixed Ahead of Monday's Bell
by Mark Vickery
We begin a new week of trading on a relatively even keel. Pre-market futures are pretty flat.
Do Options Traders Know Something About Salesforce (CRM) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Salesforce (CRM) stock based on the movements in the options market lately.
Nvidia, Salesforce, Lululemon and Best Buy are part of Zacks Earnings Preview
by Zacks Equity Research
Nvidia, Salesforce, Lululemon and Best Buy have been highlighted in this Earnings Preview article.
A Closer Look at Retail and Nvidia Earnings
by Sheraz Mian
Nvidia has established itself as a true leader of the coming artificial intelligence (AI) economy, with its next set of results scheduled to come after the market's close on Wednesday, August 28th. What can investors expect?
Unveiling Salesforce.com (CRM) Q2 Outlook: Wall Street Estimates for Key Metrics
by Zacks Equity Research
Beyond analysts' top -and-bottom-line estimates for Salesforce.com (CRM), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended July 2024.
Should You Buy, Sell or Hold Salesforce (CRM) Ahead of Q2 Earnings?
by Anirudha Bhagat
The growing adoption of generative AI-enabled solutions and the continued cloud migration are likely to have aided Salesforce's (CRM) Q2 performance.
Salesforce.com (CRM) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Salesforce.com (CRM) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Salesforce.com (CRM) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Salesforce.com (CRM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zoom Video (ZM) Upgrades Webinars to Host 1 Million Attendees
by Zacks Equity Research
Zoom Video (ZM) upgrades its Zoom Webinars with a single-use webinar offering, which can host up to one million attendees.
Salesforce.com (CRM) Increases Yet Falls Behind Market: What Investors Need to Know
by Zacks Equity Research
Salesforce.com (CRM) concluded the recent trading session at $265.38, signifying a +0.94% move from its prior day's close.
Salesforce (CRM) Dips 8% in 3 Months: What Should Investors Do Now?
by Anirudha Bhagat
Given Salesforce's (CRM) decelerating sales growth amid softening IT spending along with competitive pressure, it is prudent to stay away from investing in the stock right now.